Request for Covid-19 Impact Assessment of this Report
Geographically, the global Neuromodulation market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Neuromodulation market in North America.
Significant participants active in the global Neuromodulation market include: EnteroMedics Inc, LivaNova PLC, Nevro Corporation, St. Jude Medical, Inc., Synapse Biomedical, Inc., Bioness Inc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Medtronic plc, NeuroPace Inc....
Global Neuromodulation Market Segmentation:
Neuromodulation market, by Neuromodulation type:
Spinal Cord Stimulation (SCS)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other
…
Neuromodulation market, by Application:
Chronic Pain
Parkinson's Disease
Urinary Fecal Incontinence
Refractory Epilepsy
Essential Tremor
Dystonia
Gastroparesis
Treatment-Resistant Depression (TRD)
Obsessive Compulsive Disorder (OCD)
Other
…
Neuromodulation Market Research Report 2014-2026, by region:
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Pan Asia Pacific
China
Japan
South Korea
South East Asia Region
India
Australia
Middle East and Africa
Saudi Arabia
UAE
Qatar
Egypt
Nigeria
South Africa
Rest of MEA
The database is running updated by a group of research experts to always reflect the latest trends and information.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Neuromodulation by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Neuromodulation Market-Segmentation
4.1 By Type
4.1.1 Spinal Cord Stimulation (SCS)
4.1.2 Deep Brain Stimulation (DBS)
4.1.3 Sacral Nerve Stimulation (SNS)
4.1.4 Vagus Nerve Stimulation (VNS)
4.1.5 Other
4.2 By End-User/Application Industry
4.2.1 Chronic Pain
4.2.2 Parkinson's Disease
4.2.3 Urinary Fecal Incontinence
4.2.4 Refractory Epilepsy
4.2.5 Essential Tremor
4.2.6 Dystonia
4.2.7 Gastroparesis
4.2.8 Treatment-Resistant Depression (TRD)
4.2.9 Obsessive Compulsive Disorder (OCD)
4.2.10 Other
4.3 By Geography
4.3.1 North America Neuromodulation Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Neuromodulation Production from 2014-2020
4.3.1.2 North America Neuromodulation Consumption from 2014-2020
4.3.1.3 North America Neuromodulation Import and Export from 2014-2020
4.3.1.4 North America Neuromodulation Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Neuromodulation Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Neuromodulation Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Neuromodulation Participants Value ($) and Market Share (%) in 2019
4.3.2 Europe Neuromodulation Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Neuromodulation Production from 2014-2020
4.3.2.2 Europe Neuromodulation Consumption from 2014-2020
4.3.2.3 Europe Neuromodulation Import and Export from 2014-2020
4.3.2.4 Europe Neuromodulation Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Neuromodulation Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Neuromodulation Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Neuromodulation Participants Value ($) and Market Share (%) in 2019
4.3.3 Asia-Pacific Neuromodulation Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Neuromodulation Production from 2014-2020
4.3.3.2 Asia-Pacific Neuromodulation Consumption from 2014-2020
4.3.3.3 Asia-Pacific Neuromodulation Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Neuromodulation Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Neuromodulation Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Neuromodulation Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Neuromodulation Participants Value ($) and Market Share (%) in 2019
4.3.4 Latin America Neuromodulation Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Neuromodulation Production from 2014-2020
4.3.4.2 Latin America Neuromodulation Consumption from 2014-2020
4.3.4.3 Latin America Neuromodulation Import and Export from 2014-2020
4.3.4.4 Latin America Neuromodulation Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Neuromodulation Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Neuromodulation Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Neuromodulation Participants Value ($) and Market Share (%) in 2019
4.3.5 Middle East & Africa Neuromodulation Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Neuromodulation Production from 2014-2020
4.3.5.2 Middle East & Africa Neuromodulation Consumption from 2014-2020
4.3.5.3 Middle East & Africa Neuromodulation Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Neuromodulation Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Neuromodulation Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Neuromodulation Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Neuromodulation Participants Value ($) and Market Share (%) in 2019
5. Competitive Intelligence – Company Profiles
5.1 EnteroMedics Inc
5.1.1 EnteroMedics Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 EnteroMedics Inc Sales, Growth Rate and Global Market Share from 2014-2020
5.2 LivaNova PLC
5.2.1 LivaNova PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 LivaNova PLC Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Nevro Corporation
5.3.1 Nevro Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Nevro Corporation Sales, Growth Rate and Global Market Share from 2014-2020
5.4 St. Jude Medical, Inc.
5.4.1 St. Jude Medical, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 St. Jude Medical, Inc. Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Synapse Biomedical, Inc.
5.5.1 Synapse Biomedical, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Synapse Biomedical, Inc. Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Bioness Inc.
5.6.1 Bioness Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Bioness Inc. Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Boston Scientific Corporation
5.7.1 Boston Scientific Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Boston Scientific Corporation Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Aleva Neurotherapeutics SA
5.8.1 Aleva Neurotherapeutics SA Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Aleva Neurotherapeutics SA Sales, Growth Rate and Global Market Share from 2014-2020
5.9 BioControl Medical
5.9.1 BioControl Medical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 BioControl Medical Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Medtronic plc
5.10.1 Medtronic plc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Medtronic plc Sales, Growth Rate and Global Market Share from 2014-2020
5.11 NeuroPace Inc.
5.11.1 NeuroPace Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 NeuroPace Inc. Sales, Growth Rate and Global Market Share from 2014-2020
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of the Global Neuromodulation Market from 2021-2026
7.1 Future Forecast of Global Neuromodulation Market from 2021-2026 Segment by Region
7.2 Future Forecast of the Global Neuromodulation Market from 2021-2026 Segment by Types
7.3 Future Forecast of the Global Neuromodulation Market from 2021-2026 Segment by End-User/Applications
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
9 Disclaimer
Global Neuromodulation Market Value ($) and Growth Rate of Neuromodulation from 2014-2026
Global Neuromodulation Production and Growth Rate Segment by Product Types from 2014-2026F
Global Neuromodulation Consumption and Growth Rate Segment by End-User/Application from 2014-2026E
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Neuromodulation Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Neuromodulation Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Spinal Cord Stimulation (SCS) of Neuromodulation
Figure Deep Brain Stimulation (DBS) of Neuromodulation
Figure Sacral Nerve Stimulation (SNS) of Neuromodulation
Figure Vagus Nerve Stimulation (VNS) of Neuromodulation
Figure Other of Neuromodulation
Table Global Neuromodulation Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Neuromodulation Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Chronic Pain of Neuromodulation
Figure Parkinson's Disease of Neuromodulation
Figure Urinary Fecal Incontinence of Neuromodulation
Figure Refractory Epilepsy of Neuromodulation
Figure Essential Tremor of Neuromodulation
Figure Dystonia of Neuromodulation
Figure Gastroparesis of Neuromodulation
Figure Treatment-Resistant Depression (TRD) of Neuromodulation
Figure Obsessive Compulsive Disorder (OCD) of Neuromodulation
Figure Other of Neuromodulation
Table Global Neuromodulation Production Value ($) by Regions
Table Global Neuromodulation Production Value Share by Regions
Table Global Neuromodulation Production by Regions
Table Global Neuromodulation Production Share by Regions
Table Global Neuromodulation Consumption by Regions
Table Global Neuromodulation Consumption Share by Regions
Figure North America Neuromodulation Production and Growth Rate from 2014-2020
Figure North America Neuromodulation Consumption and Growth Rate from 2014-2020
Table North America Neuromodulation Import and Export from 2014-2020
Table North America Neuromodulation Value ($) and Growth (%) by Type from 2019-2020
Table North America Neuromodulation Value ($) and Growth (%) by Application from 2019-2020
Table North America Neuromodulation Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Neuromodulation Participants Value ($) and Market Share (%) in 2019
Figure Europe Neuromodulation Production and Growth Rate from 2014-2020
Figure Europe Neuromodulation Consumption and Growth Rate from 2014-2020
Table Europe Neuromodulation Import and Export from 2014-2020
Table Europe Neuromodulation Value ($) and Growth (%) by Type from 2019-2020
Table Europe Neuromodulation Value ($) and Growth (%) by Application from 2019-2020
Table Europe Neuromodulation Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Neuromodulation Participants Value ($) and Market Share (%) in 2019
Figure Asia-Pacific Neuromodulation Production and Growth Rate from 2014-2020
Figure Asia-Pacific Neuromodulation Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Neuromodulation Import and Export from 2014-2020
Table Asia-Pacific Neuromodulation Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Neuromodulation Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Neuromodulation Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Neuromodulation Participants Value ($) and Market Share (%) in 2019
Figure Latin America Neuromodulation Production and Growth Rate from 2014-2020
Figure Latin America Neuromodulation Consumption and Growth Rate from 2014-2020
Table Latin America Neuromodulation Import and Export from 2014-2020
Table Latin America Neuromodulation Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Neuromodulation Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Neuromodulation Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Neuromodulation Participants Value ($) and Market Share (%) in 2019
Figure Middle East & Africa Neuromodulation Production and Growth Rate from 2014-2020
Figure Middle East & Africa Neuromodulation Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Neuromodulation Import and Export from 2014-2020
Table Middle East & Africa Neuromodulation Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Neuromodulation Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Neuromodulation Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Neuromodulation Participants Value ($) and Market Share (%) in 2019
Table EnteroMedics Inc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure EnteroMedics Inc Sales and Growth Rate from 2014-2020
Figure EnteroMedics Inc Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table LivaNova PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure LivaNova PLC Sales and Growth Rate from 2014-2020
Figure LivaNova PLC Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Nevro Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Nevro Corporation Sales and Growth Rate from 2014-2020
Figure Nevro Corporation Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table St. Jude Medical, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure St. Jude Medical, Inc. Sales and Growth Rate from 2014-2020
Figure St. Jude Medical, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Synapse Biomedical, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Synapse Biomedical, Inc. Sales and Growth Rate from 2014-2020
Figure Synapse Biomedical, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Bioness Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Bioness Inc. Sales and Growth Rate from 2014-2020
Figure Bioness Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Boston Scientific Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Boston Scientific Corporation Sales and Growth Rate from 2014-2020
Figure Boston Scientific Corporation Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Aleva Neurotherapeutics SA Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Aleva Neurotherapeutics SA Sales and Growth Rate from 2014-2020
Figure Aleva Neurotherapeutics SA Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table BioControl Medical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure BioControl Medical Sales and Growth Rate from 2014-2020
Figure BioControl Medical Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Medtronic plc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Medtronic plc Sales and Growth Rate from 2014-2020
Figure Medtronic plc Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table NeuroPace Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure NeuroPace Inc. Sales and Growth Rate from 2014-2020
Figure NeuroPace Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Neuromodulation Value ($) and Growth Rate Forecast by Regions (2021-2026)
Table Global Neuromodulation Production and Growth Rate Forecast by Regions (2021-2026)
Table Global Neuromodulation Consumption and Growth Rate Forecast by Regions (2021-2026)
Table Global Neuromodulation Production and Growth Rate Forecast by Types (2021-2026)
Table Global Neuromodulation Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...